Thyroid Gland Disorder Treatment Market By Treatment Type (Medications {Thyroid Hormone Replacement Therapy, Anti-Thyroid Medications, Radioactive Iodine Therapy, Beta-blockers, Corticosteroids}, Surgical Procedures {Thyroidectomy}, Other), By Thyroid Type (Hypothyroidism, Hyperthyroidism, Thyroid Cancer, Goiter, Thyroiditis, Graves’ Disease), By Route of Administration (Oral, Intravenous, Others), By End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Home Care, Pharmacies), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Treatment Type

• Medications
  • Thyroid Hormone Replacement Therapy
  • Anti-Thyroid Medications
  • Radioactive Iodine Therapy
  • Beta-blockers
  • Corticosteroids
• Surgical Procedures
  • Thyroidectomy
• Other

By Thyroid Type

• Hypothyroidism
• Hyperthyroidism
• Thyroid Cancer
• Goiter
• Thyroiditis
• Graves' Disease

By Route of Administration

• Oral
• Intravenous
• Others

By End-User

• Hospitals and Clinics
• Ambulatory Surgical Centres
• Home Care
• Pharmacies

By Region

North America

• The U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• AbbVie Inc.
• Eli Lilly and Company
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Johnson & Johnson
• AstraZeneca PLC
• Takeda Pharmaceutical Company Limited
• Sanofi S.A.
• Bristol-Myers Squibb
• GlaxoSmithKline PLC
• Amgen Inc.
• Roche Holding AG
• Mylan N.V.
• Astellas Pharma Inc.
• Horizon Therapeutics
• Endo Pharmaceuticals Inc.
• Sun Pharmaceutical Industries Ltd.